All the latest from Verge

Read our most recent News, Publications, and Blog posts.

News·June 17, 2026

STAT News: “Verge Labs’ new AI model solves patient stratification problems for neurology clinical trials”
Verge’s CEO, Alice Zhang, and Head of Product & Engineering, Emily Ripka, spoke to STAT News about the release of vBx-1.0, the company’s breakthrough foundation model for precision neurology.
Read more

News·June 16, 2026

Verge Labs Unveils vBx: A Breakthrough Foundation Model for Precision Neurology
By Verge Labs
Read more

Report·June 16, 2026

Introducing vBx-1.0
By Verge Labs
Read more

News·June 9, 2026

Verge Labs and Tenacia Biotechnology Partner to Advance Tenacia’s CNS Pipeline Using Human Data
By Verge Labs
Read more

Blog·May 27, 2026

Why We’re Becoming Verge Labs
By Alice Zhang
Read more

Blog·May 27, 2026

What We Learned From The Trial of Our First AI-Discovered Drug
By Alice Zhang
Read more

Publication·February 1, 2026

Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition With VRG50635
By Gontier G, Kim G + 17 more
Read more

News·April 7, 2025

Digital biomarkers detect short-term ALS progression in VRG50635 trial run-in
By Verge Genomics
Read more

News·November 20, 2024

Lilly selects two ALS targets from CONVERGE® collaboration
By Verge Genomics
Read more

Publication·January 1, 2024

Unravelling cell type-specific responses to Parkinson’s Disease at single cell resolution
By Martirosyan A, Ansari R + 14 more
Read more

News·November 29, 2023

VRG50635 proof-of-concept study initiated in patients with ALS
By Verge Genomics
Read more

News·October 31, 2023

Verge Genomics and the Pritzker Consortium form schizophrenia research collaboration
By Verge Genomics
Read more

News·September 8, 2023

Verge Genomics and Alexion launch AI-enabled drug discovery collaboration for rare neuro diseases
By Verge Genomics
Read more

News·June 15, 2023

Positive Phase 1 safety and tolerability data for VRG50635
By Verge Genomics
Read more

Publication·December 1, 2022

Single-nucleus co-expression networks of dopaminergic neurons support iron accumulation as a plausible explanation to their vulnerability in Parkinson’s disease
By Gómez-Pascual A, Martirosyan A + 12 more
Read more

News·November 14, 2022

Alice Zhang named to Fortune 40 Under 40 and Fierce Biotech’s Fiercest Women in Life Sciences
By Verge Genomics
Read more

News·October 31, 2022

First-in-human dosing of VRG50635 begins in Phase 1 trial
By Verge Genomics
Read more

News·October 12, 2022

Alice Zhang honored by Goldman Sachs as one of 2022’s Most Exceptional Entrepreneurs
By Verge Genomics
Read more

News·September 12, 2022

Fierce Biotech names Verge Genomics a 2022 “Fierce 15” biotech company
By Verge Genomics
Read more

Publication·February 1, 2022

Systematic comparative analysis of strand-specific RNA-seq library preparation methods for low input samples
By Naphade S, Bhatnagar R + 3 more
Read more

News·July 8, 2021

Verge Genomics and Eli Lilly announce three-year ALS collaboration
By Verge Genomics
Read more

News·October 5, 2020

New approach for uncovering novel drug targets from human genetics published in PLOS Computational Biology
By Verge Genomics
Read more

Publication·June 1, 2020

A framework for integrating directed and undirected annotations to build explanatory models of cis-eQTL data
By Lamparter D, Bhatnagar R + 4 more
Read more

Publication·February 1, 2018

Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons
By Shi Y, Lin S + 7 more
Read more